IBM Corporation (US), IQVIA Holdings (US), OpenText Corporation (Canada), Optum (US), and Premier (US) are the Leading Players in the Patient Registry Software market
The global patient registry software market is projected to reach USD 2.8 billion by 2026 from USD 1.4 billion in 2021, at a CAGR of 15.0% during the forecast period. The growth of this market is mainly attributed to the shift toward computerized registries to provide users with an automated way to store data and create, sort, and display patient lists for use in planning, quality improvement, reporting, and direct care delivery. Also, the emergence of the COVID-19 pandemic and the increasing number of COVID-19 patients globally are expected to increase the demand for patient registry software in the coming years. Moreover, factors such as rising number of accountable care organizations and high adoption rate of the subscription model are creating lucrative opportunities for the market players.
The global patient registry software market is fragmented with the presence of many regional and global players like IBM Corporation (US), IQVIA Holdings (US), OpenText Corporation (Canada), Optum (US), Premier, Inc. (US) are the major players in this market. These companies are majorly focusing on the strategies such as agreements, collaborations, partnerships, and service launches in order to remain competitive and further increase their share in the market. Some of the prominent players in the market namely, ArborMetrix, Inc. (US), FIGmd (US), McKesson Corporation (US), Syneos Health (US), Dacima Software, Inc. (Canada), ifa Systems AG (Germany), Medstreaming- M2S (US), ImageTrend, Inc. (US), Evado Clinical (Australia), WIRB Copernicus Group (US), Global Vision Technologies, Inc. (India), Conduent, Inc. (US), Elekta AB (Sweden), Cedaron (US), LUMEDX (US), Armus Corp (US), Phamax AG (Switzerland), and Versaform Systems Corp (US), ESO Solutions (US) and Ordinal Data, Inc. (US).
To know about the assumptions considered for the study download the pdf brochure
IBM Corporation dominated the patient registry market in 2020. The company’s leading position can be attributed to its broad product portfolio and wide geographic presence. The company mainly focuses on providing PHM solutions to government organizations, TPAs, companies, hospitals, and research centers. The company has a wide geographical presence encompassing the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company has shown a focus on partnerships & collaborations for growth.
IQVIA Holdings is the second-largest player in the patient registry software market. It offers a wide range of software and solutions. The company has a wide R&D platform with data spanning 300,000+ clinical investigators, 487 indications, and 18 therapeutic areas. Besides, the company’s highly skilled workforce of approximately 7,000 employees gives it a competitive edge. The company is also providing hospital partners with a COVID-19 registry platform and technology-powered trial matching solution. Moreover, it has focused on expanding its presence through partnerships and product launches.
Related Reports:
Patient Registry Software Market by Type of Registry (Diabetes, Cancer, Rare Disease, Asthma, Kidney), Software (Integrated and Standalone), Delivery (On Premise and Cloud), Pricing Model, Database (Public), End User (Hospitals) - Global Forecast to 2026
Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
[email protected]
- Triangulate with your Own Data
- Get Data as per your Format and Definition
- Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
- Any level of Personalization
- What are the Known and Unknown Adjacencies Impacting the Patient Registry Software Market
- What will your New Revenue Sources be?
- Who will be your Top Customer; what will make them switch?
- Defend your Market Share or Win Competitors
- Get a Scorecard for Target Partners
